Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Is reduced dose of direct oral anticoagulants (doac) a risk of ischaemic stroke events?
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: UEDA, Aya (Meiji Pharmaceutical University)
- Co-author(s): Aya Ueda: Pharmacy , St. Marianna School of Medicine Hospital, Kawasaki, Japan;, Meiji Pharmaceutical University, Tokyo, Japan
Manabu Akazawa: Meiji Pharmaceutical University, Tokyo, Japan
BackgroundDOAC approved for prevention of ischaemic stroke for nonvalvular AF (NVAF) patients. DOAC offer clearly attractive features such as fixed dose and lack of required blood monitoring. However, dose adjustments of DOAC are recommended. In clinical practice, the dose reductions were often not based on manufactures labelling.
MethodsWe.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019